Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

A cross sectional study of HPV type prevalence according to age and cytology.

Argyri E, Papaspyridakos S, Tsimplaki E, Michala L, Myriokefalitaki E, Papassideri I, Daskalopoulou D, Tsiaoussi I, Magiakos G, Panotopoulou E.

BMC Infect Dis. 2013 Jan 30;13:53. doi: 10.1186/1471-2334-13-53.

2.

Human papillomavirus genotyping and e6/e7 mRNA expression in greek women with intraepithelial neoplasia and squamous cell carcinoma of the vagina and vulva.

Tsimplaki E, Argyri E, Michala L, Kouvousi M, Apostolaki A, Magiakos G, Papassideri I, Panotopoulou E.

J Oncol. 2012;2012:893275. doi: 10.1155/2012/893275.

3.

Prevalence of human papillomavirus types 6, 11, 16, 18, 31, and 33 in a cohort of Greek women.

Panotopoulou E, Tserkezoglou A, Kouvousi M, Tsiaousi I, Chatzieleftheriou G, Daskalopoulou D, Magiakos G.

J Med Virol. 2007 Dec;79(12):1898-905.

PMID:
17935171
4.

Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.

Tserkezoglou A, Kontou S, Hadjieleftheriou G, Apostolikas N, Vassilomanolakis M, Sikiotis K, Salamalekis E, Tseke P, Magiakos G.

Anticancer Res. 2006 May-Jun;26(3B):2339-44.

5.

Solitary parenchymal splenic recurrence of ovarian adenocarcinoma: a case report and review of the literature.

Tserkezoglou A, Kontou S, Hatjieleftheriou G, Nikolaidou ME, Plataniotis G, Apostolikas N, Magiakos G.

Anticancer Res. 2005 Mar-Apr;25(2B):1471-6. Review.

Supplemental Content

Loading ...
Support Center